SCM
NEO icon

Stevens Capital Management’s NeoGenomics NEO Stock Holding History

Stevens Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-12,575
Closed -$59K – 1174
2015
Q1 		$59K Buy
+12,575
New +$54.7K ﹤0.01% 944

Other funds holding NEO

CRC
Curi RMB Capital Chicago, Illinois $6.48B AUM 30.25% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stevens Capital Management's NEO Position: Q2 2015 in Review

Stevens Capital Management sold out of NeoGenomics (NEO) in Q2 2015, closing a stake of 12,575 shares — an estimated $59K sold.

Stevens Capital Management first reported a position in NEO in Q1 2015 and held it in 1 quarter. The position peaked at $59K in Q1 2015. 97 funds tracked by Wall St. Rank hold NEO as of Q2 2015.

  • Stevens Capital Management reported no remaining NeoGenomics position as of Q2 2015 after selling out during the quarter.
  • Stevens Capital Management sold 12,575 NeoGenomics shares in Q2 2015, an estimated $59K.
  • Stevens Capital Management first reported a position in NeoGenomics in Q1 2015 and held it in 1 quarter.
  • Stevens Capital Management's NeoGenomics position peaked at $59K in Q1 2015.
  • 97 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2015.

Based on Stevens Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.